Genetically-modified cell lines: categorisation and considerations for characterisation

Stem Cell Res. 2020 Dec:49:102103. doi: 10.1016/j.scr.2020.102103. Epub 2020 Nov 30.

Abstract

Stem Cell Research is pleased to introduce into its publication portfolio a new article type: a template-driven short report on the generation of a novel Genetically Modified Cell Line. This resource type is typically derived from human pluripotent stem cell lines via the introduction of nucleases and/or foreign genetic material leading to stable genomic alterations, maintained in a single cell-derived clonal cell line. Interest in, and demand for, genetically modified cell lines has grown exponentially in the last few years. This overview provides a brief introduction to this incredibly versatile lab resource and marks the beginning of a new and exciting addition to the publication portfolio of Stem Cell Research. A dramatic increase in the accessibility of the human genome in the last decade has given a long-anticipated boost to advanced biomedical studies in human in vitro systems. Pluripotent stem cells represent a particularly attractive gateway into this line of experimentation due to their unique suitability for the isolation of clonal genetically modified cell lines (GMCLs), and the ability to be differentiated into essentially any cell type upon the lines' virtually limitless expansion.

Keywords: CRISPR/Cas, off-target mutagenesis, random insertions, primed editing; Genetic modification; Genome editing.

MeSH terms

  • CRISPR-Cas Systems*
  • Cell Line
  • Endonucleases / genetics
  • Genome, Human
  • Humans
  • Pluripotent Stem Cells* / metabolism

Substances

  • Endonucleases